Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/1991
12/10/1991US5071875 Substituted 2-amidotetralins as melatonin agonists and antagonists
12/10/1991US5071847 Bis (aryl) alkene compounds of homopiperidines useful as serotonin-antagonists
12/04/1991EP0459568A2 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
12/04/1991EP0459449A1 Furano[2,3-F]isoindoles as aldose reductase inhibitors
12/04/1991EP0459148A2 Dry eye treatment composition
12/01/1991CA2043385A1 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
11/1991
11/27/1991EP0458661A1 Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments
11/27/1991EP0458642A1 Amino bicyclic compounds
11/27/1991EP0458590A1 Treatment of ocular hypertention with a synergistic combination
11/27/1991EP0458589A1 Treatment of ocular hypertension with an ocular synergistic combination
11/27/1991EP0458588A1 Treatment of ocular hypertension with a synergistic combination for ocular administration
11/27/1991EP0458587A1 Synergistic combination for ophthalmic use
11/27/1991EP0458551A1 Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
11/27/1991EP0458549A1 N-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
11/26/1991US5068332 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
11/26/1991US5068239 Tetrazoleacetic acid derivatives and use for aldose reductase inhibitory activity
11/21/1991EP0457586A1 4-alkylamino-6-(C3-5-hydrocarbyl)thieno [2,3-B] thiopyran-2-sulfonamide-7,7-dioxides
11/19/1991US5066676 Sulfonamido derivative inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them
11/18/1991CA2042638A1 4-alkylamino-6-(c3-5-hydrocarbyl)thieno [2,3-b]thiopyran-2-sulfonamide-7,7-dioxides
11/17/1991CA2017037A1 Composition for treatment of progressive myopia
11/13/1991EP0456209A2 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
11/13/1991EP0455909A2 5-[1-(Imidazol)methyl]-3,3-disubstituted-2(3H) furanone derivatives
11/12/1991US5064758 Method of preparing a mixture of ribonucleotides
11/06/1991EP0455596A1 Substituted Indoles
11/06/1991EP0455396A1 Aqueous gel compositions and their use
11/06/1991EP0455264A2 Ocular hypotensive agents
11/06/1991EP0455263A2 Non-pyrogenic and non-irritating composition comprising sodium hyaluronate
11/06/1991EP0455093A2 Use of a tumor necrosis factor for facilitating nerve regeneration
11/06/1991CN1055874A Aqueous ophthalmic solutions and method for preserving same
11/05/1991US5063061 Antiallergens
11/05/1991CA2041745A1 Substituted indoles
10/1991
10/31/1991WO1991016070A1 Enzymatic disinsertion of vitreous body
10/31/1991WO1991016066A1 Composition and treatment with biologically active peptides and toxic cations
10/30/1991EP0454617A1 Treatment of sinus headache
10/30/1991EP0454511A1 N-substituted heterocycle derivatives, their preparation, compositions containing them
10/29/1991US5061734 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
10/24/1991CA2040965A1 Pharmaceutical compositions comprising tnf for induction of nerve regeneration
10/24/1991CA2040510A1 Composition and treatment with biologically active peptides and toxic cations
10/23/1991EP0453337A2 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmic use
10/23/1991EP0453288A1 Enantiospecific synthesis of S(+)-5,6-dihydro-4-(R-amino)-4H thieno (2,3-B)thiopyran-2-sulfonamide-7,7-dioxide
10/23/1991EP0453195A1 (S)-alkyl 3-(thien-2-ylthio) butyrate and analogs and synthesis thereof
10/23/1991EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity
10/22/1991US5059613 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
10/19/1991CA2040605A1 (s)-alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereof
10/19/1991CA2040604A1 Enantiospecific synthesis of s-(+)-5,6-dihydro-4-(r-amino)-4h-thieno[2,3-b] thiopyran-2-sulfonamide-7,7-dioxide
10/19/1991CA2039566A1 Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
10/17/1991WO1991015479A1 Substituted pyrazoles, isoxazoles and isothiazoles
10/17/1991CA2079343A1 Substituted pyrazoles, isoxazoles and isothiazoles
10/15/1991US5057496 Dipeptide compounds containing histidine or n-methyl histidine processes for their preparation and compositions containing them
10/14/1991WO1991016313A1 Substituted benzimidazoles
10/14/1991CA2077897A1 Substituted benzimidazoles
10/10/1991WO1991015486A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors
10/09/1991EP0451082A1 Ophthalmic product
10/09/1991EP0450080A1 Composition for the treatment of progressive myopia
10/08/1991US5055598 Benzopyran derivatives
10/08/1991US5055480 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
10/08/1991US5055467 Pharmaceutical epinephrine-pilocarpine compounds
10/08/1991US5055452 Skin disorders
10/08/1991US5055304 Containing disodium adenosine triphosphate and low melting fat or oil-like component; cardiovascular disorders, asthenopia
10/08/1991US5055302 Nearsightedness
10/06/1991WO1991015491A1 Heterocyclic compounds as aldose reductase inhibitors
10/06/1991CA2078210A1 Heterocyclic compounds as aldose reductase inhibitors
10/05/1991WO1991015229A1 Modified heparin binding growth factors
10/05/1991CA2079604A1 Modified heparin binding growth factors
10/01/1991WO1991015209A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines
10/01/1991US5053547 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991CA2079344A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines
10/01/1991CA1289952C N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas, processes for their preparation, and their use in medicaments
09/1991
09/28/1991WO1991014674A2 5-lipoxygenase inhibitors
09/28/1991CA2078126A1 5-lipoxygenase inhibitors
09/28/1991CA2039055A1 Treatment of sinus headache
09/25/1991EP0448253A2 Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
09/25/1991EP0447962A1 Labdanes and process for their preparation
09/24/1991US5051445 3-amino-propyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
09/24/1991US5051402 Fungicides, immunosuppressants and antiphlogistic agents
09/21/1991WO1991014679A1 Heterocyclic n-substituted derivatives, their preparation and thepharmaceutical compositions containing them
09/20/1991WO1991014683A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991WO1991014682A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991WO1991014428A1 USE OF 5-TRANS PROSTAGLANDIN F2α AS AN OCULAR HYPOTENSIVE AGENT
09/20/1991CA2095050A1 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2077995A1 Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
09/20/1991CA2076023A1 Use of 5-trans prostaglandin f as an ocular hypotensive agent
09/19/1991WO1991013869A1 15-deoxyprostaglandin derivative
09/18/1991EP0447324A1 2,4-Pyrimidinedione derivatives and medicines containing them
09/18/1991EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity
09/18/1991EP0446230A1 Treatment of myelosuppression associated with acquired immune deficiency
09/18/1991CA2038405A1 Labdanes and process for their preparation
09/17/1991WO1991013619A1 Nitroxides as protectors against oxidative stress
09/17/1991US5049658 Polypeptide with cell-spreading activity
09/17/1991US5049587 Mabuterol
09/17/1991CA1289144C N-substituted 2-amino-thiazoles, process for their preparation and their therapeutic application
09/17/1991CA1289139C Quinazoline derivatives and a process for their production
09/16/1991CA2038198A1 2,4-pyrimidinedione derivatives and pharmaceutical compositions containing them
09/14/1991CA2037990A1 Amino acid derivatives
09/13/1991WO1991013620A1 USE OF PROSTAGLANDIN F3α AS AN OCULAR HYPOTENSIVE AGENT
09/13/1991CA2075951A1 Use of prostaglandin f3.alpha.as an ocular hypotensive agent
09/11/1991EP0446062A1 C-Linked pyrazole derivatives
09/11/1991EP0445781A1 3-Arylcarbonyl-1-aminoalkyl-1H-indole containing antiglaucoma compositions
09/10/1991US5047593 Lipoxygenase inhibiting compounds
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 531